CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 23 enrolled
Drug / intervention
Integrating Nuanced Support for Perinatal adherence and Depressionbehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03069417
NCT03069417N/ACompleted

Project INSPireD: Integrating Nuanced Support for Perinatal Adherence and Depression

Massachusetts General Hospital·interventional·Posted Mar 3, 2017·Updated Dec 14, 2021

In Brief

A clinical study evaluating Integrating Nuanced Support for Perinatal adherence and Depression for Human Immunodeficiency Virus and Depression. Completed, enrolled 23 participants across 2 sites in 2 countries.

Detailed Summary

The main aim was to conduct a pilot field test of a group-based depression and adherence counseling intervention with HIV-infected women in the perinatal period. Participants were HIV-infected women living in KwaZulu-Natal, South Africa.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesSouth Africa, United States

Timeline

N/ACompletedFinished
2017201820192020202120222023202420252026
First PostedMar 3, 2017
Enrollment StartNov 9, 2016
Primary CompletionMar 24, 2017
Study CompletionOct 31, 2017
TodayJul 2, 2026
Enrollment to primary: 5 monthsPosted 9.3 years ago

Interventions

Integrating Nuanced Support for Perinatal adherence and Depressionbehavioral

A 5-8 session intervention to decrease depressive symptoms and improve antiretroviral adherence among HIV-infected pregnant and postpartum women